Investors Sue In Del. For Cartesian Therapeutics Vote Hold
Stockholders of early-stage biotech venture Cartesian Therapeutics Inc. sought a Delaware Court of Chancery order Wednesday to enjoin a meeting on a planned post-merger stock conversion and reverse split, pending additional...To view the full article, register now.
Already a subscriber? Click here to view full article